Skip to content
View page with normal contrast
View page with high contrast
Viagra Sildenafil
Kamagra Australia
Biomedical
Kamagra Jelly
climateinstitute
Home
About
Health Professionals
Viagra Sildenafil
Kamagra Australia
Biomedical
Kamagra Jelly
climateinstitute
About the HPV Register
Announcements
Documents
Useful links
Parents & Teens
About the HPV Register
FAQs
Useful links
Research & Data
Research Overview
Coverage Data
Relevant Research Publications
Useful links
HPV Vaccination Coverage 2016 - Male
National (Australia) HPV 3 dose vaccination coverage for males turning 15 years of age in 2016
State
Estimated
Resident
Population
(as at
30/06/2016)
Coverage Dose 1
Coverage Dose 2
Coverage Dose 3
Total
Doses
n
%
n
%
n
%
ACT
2,208
1,903
86.2%
1,833
83.0%
1,576
71.4%
5,312
NSW
46,593
37,556
80.6%
36,490
78.3%
34,715
74.5%
108,761
NT
1,640
1,584
96.6%
1,476
90.0%
1,348
82.2%
4,408
QLD
31,725
25,380
80.0%
24,388
76.9%
22,473
70.8%
72,241
SA
10,070
8,404
83.5%
8,090
80.3%
7,309
72.6%
23,803
TAS
3,279
2,568
78.3%
2,394
73.0%
2,092
63.8%
7,054
VIC
35,861
29,866
83.3%
28,772
80.2%
26,709
74.5%
85,347
WA
15,625
13,489
86.3%
13,046
83.5%
12,202
78.1%
38,737
NAT
147,001
120,750
82.1%
116,489
79.2%
108,424
73.8%
345,663
National (Australia) HPV 3 dose vaccination coverage for males turning 15 years of age in 2016
September 2018 | 302 KB
NOTES
Data extracted from the National HPV Vaccination Program Register (HPV Register) as at 04 JULY 2018 and includes males vaccinated between APR 2007 and JUN 2018.
Includes doses that comply with the recommended vaccine dosage and administration as per the Australian Immunisation Handbook (up to 3 doses administered at prescribed intervals).
Population is Estimated Resident Population 2016 (as at 30 June 2016) provided by the Australian Bureau of Statistics - CAT 3101.0 Australian Demographics Statistics, Tables 51 to 58: Estimated Resident Population by Single Year of Age by State and Territory, FINAL based on 2016 census data published JUN 2018.
Age is age as at date of ERP estimate (30th June).
Coverage is calculated as doses administered and reported to the HPV Register/Estimated Resident Population expressed as a percentage.
Excludes consumers who do not wish their details to be recorded on the HPV Register.
The National HPV Vaccination Program initially provided quadrivalent HPV vaccine for all females aged 12-26 years as at mid 2007 ( school program commenced April 2007 and GP/community program in July 2007) until end December 2009. From 2009 the Program offered HPV vaccination routinely to females in the first year of high school (usually at 12-13 years). From 2013, males were also offered HPV vaccination routinely in the first year of high school (age 12-13 years), with a catch-up program available for males aged 14-15 years in 2013 and 2014.
As the ages of students in the first year of high school varies between jurisdictions, age 15 is used as the age for routine review of vaccination coverage that provides the best comparison to allow for these varying ages in administration, as per World Health Organization (WHO) recommendations. These are the first national estimates for coverage in males at age 15 and reflect vaccination during the male catch-up program 2013-2014 rather than routine vaccination of males in the first year of high school.
HPV Vaccination doses administered through general practice and in other community settings may be incompletely notified to the HPV Register. The extent of under notification differs by jurisdiction, with the Northern Territory and Queensland expected to have the most complete notification, due to notification of doses via State based immunisation registers.
Research Overview
Coverage Data
Relevant Research Publications
Useful links